Table 3.
Incidence of MYD88 and CD79B mutations in primary cutaneous diffuse large B cell lymphoma, leg type compared to other subtypes of large B cell lymphoma (incidences from Wright et al. [3])
| PCDLBCL-LT | Primary CNS DLBCL | Primary testicular DLBCL | Intravascular LBCL | DLBCL in breast | MCD DLBCL | All nodal DLBCL | |
|---|---|---|---|---|---|---|---|
| MYD88 | 59% | 61% | 67% | 47% | 50% | 66% | 11% |
| CD79B | 43% | 42% | 16% | 38% | 29% | 50% | 11% |
| MYD88 + CD79B | 38% | 29% | 16% | 24% | 17% | 38% | 4% |
PCDLBCL-LT primary cutaneous diffuse large B cell lymphoma, leg type; DLBCL diffuse large B cell lymphoma; LBCL large B cell lymphoma